Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Clinical trial NCT02261883 · TERMINATED
Trial details
- NCT number
- NCT02261883
- Sponsor
- United Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-29
- Primary completion
- 2022-09-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.